- Home
- BLCO vs MTCH Comparison
BLCO vs MTCH Comparison
Compare BLCO & MTCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- MTCH
- Stock Information
- Founded
- BLCO 1853
- MTCH 1986
- Country
- BLCO Canada
- MTCH United States
- Employees
- BLCO N/A
- MTCH N/A
- Industry
- BLCO Ophthalmic Goods
- MTCH Computer Software: Programming Data Processing
- Sector
- BLCO Health Care
- MTCH Technology
- Exchange
- BLCO Nasdaq
- MTCH Nasdaq
- Market Cap
- BLCO 7.0B
- MTCH 8.2B
- IPO Year
- BLCO 2022
- MTCH 2015
- Fundamental
- Price
- BLCO $18.02
- MTCH $33.76
- Analyst Decision
- BLCO Buy
- MTCH Buy
- Analyst Count
- BLCO 12
- MTCH 20
- Target Price
- BLCO $20.91
- MTCH $37.84
- AVG Volume (30 Days)
- BLCO 524.8K
- MTCH 5.0M
- Earning Date
- BLCO 10-30-2024
- MTCH 01-28-2025
- Dividend Yield
- BLCO N/A
- MTCH 2.25%
- EPS Growth
- BLCO N/A
- MTCH 27.57
- EPS
- BLCO N/A
- MTCH 2.24
- Revenue
- BLCO $4,684,000,000.00
- MTCH $3,485,425,000.00
- Revenue This Year
- BLCO $17.39
- MTCH $5.57
- Revenue Next Year
- BLCO $6.18
- MTCH $1.75
- P/E Ratio
- BLCO N/A
- MTCH $15.04
- Revenue Growth
- BLCO 18.01
- MTCH 6.12
- 52 Week Low
- BLCO $13.16
- MTCH $27.66
- 52 Week High
- BLCO $21.69
- MTCH $42.43
- Technical
- Relative Strength Index (RSI)
- BLCO 36.81
- MTCH 56.35
- Support Level
- BLCO $17.71
- MTCH $29.95
- Resistance Level
- BLCO $18.99
- MTCH $33.58
- Average True Range (ATR)
- BLCO 0.52
- MTCH 1.25
- MACD
- BLCO -0.17
- MTCH 0.17
- Stochastic Oscillator
- BLCO 10.17
- MTCH 78.56
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About MTCH Match Group Inc.
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Hinge, BLK, Chispa, Match.com, OkCupid, PlentyOfFish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).